Center for Lyme Action Celebrates Congressional Heroes
In a significant event, Center for Lyme Action, a leading nonprofit organization committed to increasing federal funding for Lyme and tick-borne diseases, recognized remarkable lawmakers and community leaders for their invaluable support in the fight against Lyme disease. This illness is the most common vector-borne and tick-borne disease, with nearly 500,000 new cases reported annually.
Highlights of the Awards Ceremony
During this year’s annual meeting, the organization awarded the Lyme and Tick-Borne Disease Champion Award to influential members of Congress who have played a pivotal role in enhancing awareness and funding for Lyme disease. Among the honorees were prominent figures such as U.S. Senator Tammy Baldwin and U.S. Representative Diana DeGette, who have continually advocated for better health responses and increased legislative support.
Impact of Federal Funding on Lyme Disease Research
The Center for Lyme Action's awards ceremony coincides with a remarkable 169% increase in federal funding for Lyme and tick-borne diseases across various federal agencies, amounting to $158 million. While this increase is a positive step, the funding per patient remains considerably low at $90, significantly less compared to other diseases, highlighting the urgent need for more attention and resource allocation.
Commitment to Continued Advocacy
Center for Lyme Action co-founder Bonnie Crater emphasized the importance of these congressional partnerships. She stated, "Though improvements are visible, Lyme and tick-borne diseases continue to challenge millions daily. Our efforts are aimed at building a robust coalition to conquer these diseases, and the leadership demonstrated by our award recipients is crucial in this journey.”
The Kay Hagan Tick Act and Its National Strategy
Prominent legislation such as the Kay Hagan Tick Act is crucial in guiding national strategies to combat vector-borne diseases. Leaders from the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) have collaborated on a comprehensive public health strategy, establishing actionable recommendations to improve prevention, detection, and treatment.
Looking Forward in the Fight Against Lyme Disease
Lyme disease has made significant inroads in public health, with reports of its presence in every state and in at least 65 countries globally. Center for Lyme Action continues its critical role in advocating for systematic changes leading to more effective disease prevention and management strategies.
Community Support and Future Direction
Crater further remarked on the organization’s future endeavors, highlighting the importance of sustained dialogue with Congress to bolster funding initiatives and implement effective public health strategies. The organization aims to involve more stakeholders in its efforts, ensuring a unified front in combating the ongoing challenges posed by Lyme disease.
Frequently Asked Questions
What is Lyme disease?
Lyme disease is a tick-borne illness caused by bacterium Borrelia burgdorferi, which can lead to significant health issues if not treated promptly.
How does the Center for Lyme Action contribute to Lyme disease awareness?
The Center plays a pivotal role in advocating for increased federal funding and supporting research initiatives to improve understanding and treatment of Lyme disease.
Who were the honored members of Congress?
The awards recognized influential figures such as Senators Tammy Baldwin and Kirsten Gillibrand, among others, who have supported Lyme disease initiatives.
What recent developments have occurred in Lyme disease research funding?
Recent data indicates a significant increase in federal funding for Lyme disease research, aimed at enhancing overall patient care and support.
How can individuals get involved in the fight against Lyme disease?
Individuals can contribute by raising awareness, supporting legislative efforts, and engaging with community initiatives focused on Lyme disease prevention and education.
